Periodically, Project CBD publishes special, in-depth reports on important topics in cannabis and CBD science.
In early 2019 Project CBD began collecting responses to a survey we designed to figure out who is using CBD, how and why people are using CBD, what kinds of products they are consuming, and whether or not CBD is working for them. The analysis in this report covers an eight-month period and encompasses over 3500 responses.
Given the increasing acceptance and prevalence of cannabis as a therapeutic option, it’s important for physicians and patients to understand how various cannabis components interact with commonly consumed pharmaceuticals. Project CBD has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. The 33-page report is available for free download.
This handout explores the staggering scope of opioid abuse in America, and a neglected treatment option for opioid addiction: medical cannabis.
This three part series takes a deep dive into the impact of California’s cannabis regulations.
Project CBD critiques California’s proposed regulations for cannabis testing regarding pesticides, heavy metals, and solvents and makes recommendations for amending them.
This survey—a collaboration between Care By Design and Project CBD—sought to answer several questions: How satisfied are patients with cannabis as an analgesic? How does medical marijuana compare to other pain management approaches, in particular, opiates? How do the most common pain management therapies compare in terms of their impact on quality of life? Eight hundred people, most between 50 to 70 years old, responded to the survey. Over 80 percent reported that they were suffering from chronic pain; close to half reported suffering from acute pain. A significant decrease in opiate usage among elderly patients on cannabis therapy was the study’s most notable finding.
Between seven and eight percent of people will develop PTSD (Post-Traumatic Stress Disorder) in their lifetime. Among military veterans, the rates are higher. Care By Design recently surveyed 300 patients on their use of cannabis and other medications to treat PTSD. The survey asked what medications patients had been prescribed for their PTSD-related symptoms and what impact these medications—and cannabis—had on five telltale symptoms of PTSD: anxiety, depression, pain, anger or irritability, and sleep problems.
Care By Design surveyed thousands of patients who had been using CBD-rich cannabis medicines for over 30 days. They asked patients what they were taking CBD-rich cannabis for, the ratio of CBD-to-THC they were using, and about its impact on pain, discomfort, energy, mood, and overall wellbeing.
|Educational Primer on Cannabinoid-Drug Interactions||854.8 KB|
|Handout on Cannabis & Opiates||473.6 KB|
|A Response to California's Proposed Testing Requirements||1.16 MB|
|Cannabis in the Treatment of Age-Related Pain||197.1 KB|
|CBD for the Treatment of PTSD (March 2016)||2.23 MB|
|General CBD Survey (September 2015)||1.34 MB|